Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
233 USD | +3.13% | +9.35% | +0.69% |
07-15 | ANI Pharmaceuticals Launches L-Glutamine Oral Powder Following FDA Approval | MT |
07-15 | Leerink Partners Adjusts Price Target on IQVIA to $267 From $278, Maintains Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.69% | 41.16B | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B | |
-3.85% | 11.14B |
- Stock Market
- Equities
- IQV Stock
- News Iqvia Holdings Inc.
- Transcript : IQVIA Holdings Inc. - Special Call